Clinical Trials · NCT06313528
A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 85
- Start date
- Mar 2024
- Locations
- 3 sites, United States
- Primary endpoint
- Change from Baseline in Total Calorie Intake at Lunch and Dinner (Combined)